A total of 135 batches of capsules are being recalled from consumers due to concerns that the defective medication could potentially trigger cardiac arrest, as per official reports.

 

Last week, Glenmark Pharmaceuticals initiated the recall of 114 batches of potassium chloride extended-release capsules, while American Health Packaging, acting on behalf of BluePoint Laboratories, recalled 21 batches of the same capsules.

 

Here's What They're Not Telling You About Your Retirement

Label for Glenmark Pharmaceuticals Potassium Chloride Extended Release Capsules 100-count bottles, which were recalled along with 500-count bottles. FDA

 

 

Label for BluePoint Laboratories Potassium Chloride Extended Release Capsules, 750 mg, 100-count bottles. Bottles of 500 were recalled also. FDA

FREE Gun Law Map: Laws Don't Pause During Social Unrest

Who Is More Dangerous To The American Way Of Life?

By completing the poll, you agree to receive emails from RVM News, occasional offers from our partners and that you've read and agree to our privacy policy and legal statement.

 

 

The voluntary recall was prompted by the discovery of issues related to the capsules' dissolution process, raising fears of elevated potassium levels leading to hyperkalemia, as highlighted in the companies' notifications published by the US Food and Drug Administration.

 

The companies have cautioned that hyperkalemia, which can result from high potassium levels, may cause an irregular heartbeat, posing a risk of cardiac arrest.

 

Glenmark issued its recall on a Monday, with BluePoint following suit the next day. Both sets of capsules are produced by Glenmark, as reported by the Miami Herald.

 

As stated in both recalls, "To date, the firm has not received any reports of hyperkalemia or serious adverse events from spontaneous sources related to this recall."

 

These capsules are meant for patients experiencing low potassium levels, also referred to as hypokalemia, and are typically packaged in bottles of 100 and 500.

 

The FDA has published the list of recalled batch numbers for Glenmark and BluePoint on its official website.

 

 

In light of the recall, the companies have advised consumers with the affected Potassium Chloride Extended-Release Capsules to seek guidance from their physician or healthcare provider before discontinuing the product's use.

 

Additionally, consumers are urged to get in touch with their healthcare provider if they have encountered any issues that could be linked to the consumption or use of this medication.

Warning: Account balances and purchasing power no longer tell the same story. Know in 2 minutes if your retirement is working for you.